API INTERMEDIATES
1-(6-Methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone (CAS No.: 221615-75-4)
SS Pharma Group is an ISO 9001:2015 Certified Global Supplier based in India for the product CAS No.: 221615-75-4.
We offer the product CAS No.: 221615-75-4 from our manufacturer/supplier/principals for your Research and Development, Evaluation, or Commercial requirements, based on the product's availability from our network. We can also provide other required upstream or downstream intermediates along with a supportive technical package for evaluation based on the customer’s request.
We understand and respect our customers' needs for strict regulatory compliance and precise specifications by offering intermediates transparently and facilitating easy access to manufacturer/supplier/principals with affordable, high-quality raw material intermediates.
If you are looking for any upstream or downstream intermediates related to CAS No.: 221615-75-4, please feel free to email us. Based on your specific request, we will source a reliable manufacturer/supplier/principals who meet your quality standards.
CAS number:
221615-75-4
Manufacturer Certificate:
GMP, ISO Certified
| Synonyms |
2-(4-MESYLPHENYL)-1-(6-METHYLPYRIDIN-3-YL)-ETHAN-1-ONE 1-(6-Methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone |
|---|---|
| Molecular Formula | C₁₅H₁₅NO₃S |
| Manufacturer Specifications | Available upon request |
| Packing | Export-worthy packing to ensure safe transportation |
| Material Safety Data Sheet (MSDS) | Available upon request |
| Product Name | CAS No. |
|---|---|
| Etoricoxib | 202409-33-4 |
| TDP | CMC DATA |
|---|---|
| ✅ | ✅ |
Send us your Intermediates inquiries to bdteam@sspharma.com
- • Products protected by valid patents from a manufacturer are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk
- • Products currently covered by valid US Patents are offered for R&D use from a manufacturer in accordance with 35 USC 271 +A13(1)
- • Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
- • SS Pharma Group assumes no responsibility/liability in case of being imparted with goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual manufacturer. SS Pharma Group makes no representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual property which includes patents of a manufacturer in its products or services for any purpose.
- • SS Pharma Group warns the sellers not to sell any goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual or a manufacturer.
- • SS Pharma Group warns the buyers not to use/procure any goods from a manufacturer to achieve a product which might be knowingly causing an infringement of intellectual property in any manner whatsoever which includes patent rights of any individual manufacturer.
- • This website is updated and maintained by SS Pharma Group. As a matter of policy, SS Pharma Group does not entertain any anonymous or pseudonymous inquiries.
Under Development
| S# | Product Name | Therapeutic Area | QUOTE |
|---|---|---|---|
| 1 | Brivaracetam | Anticonvulsant |  |
| 2 | Bempedoic Acid | Anticoagulant | |
| 3 | Esomeprazole | Gastro-Intestinal | |
| 4 | Levetiracetam | Anticonvulsant | |
| 5 | Ranolazine | Anticoagulant | |
| 6 | Ropinirole Hydrochloride | Antiparkinson | |
| 7 | Rosuvastatin Calcium | Antilipidemic | |
| 8 | Sulindac | Anti-Inflammatory | |
| 9 | Ticagrelor | Anticoagulant | |
| 10 | Varenicline Tartrate | Anti-Smoking | |